{"product_id":"revolade-25mg-con-28-tabletas-eltrombopag","title":"Revolade 25mg with 28 Tablets (Eltrombopag)","description":"\u003ch2\u003eCategory\u003c\/h2\u003e\n\u003cp\u003eMedications\u003c\/p\u003e\n\n\u003ch2\u003eLine\u003c\/h2\u003e\n\u003cp\u003eMedications for hematological disorders\u003c\/p\u003e\n\n\u003ch2\u003eBrand\u003c\/h2\u003e\n\u003cp\u003eRevolade\u003c\/p\u003e\n\n\u003ch2\u003eMolecule\u003c\/h2\u003e\n\u003cp\u003eEltrombopag\u003c\/p\u003e\n\n\u003ch2\u003ePresentation\u003c\/h2\u003e\n\u003cp\u003e28 tablets of 25 mg\u003c\/p\u003e\n\n\u003ch2\u003eLaboratory\u003c\/h2\u003e\n\u003cp\u003eGlaxo Smith Kline\u003c\/p\u003e\n\n\u003ch2\u003eIndications\u003c\/h2\u003e\n\u003cp\u003eRevolade (Eltrombopag) is indicated for the treatment of thrombocytopathy, specifically in adult patients with thrombocytopenia (low platelet count) associated with immune thrombocytopenic purpura (ITP) who have not responded to previous treatments. It is also used in patients with chronic thrombocytopenia in the context of hepatitis C who require antiviral treatment, as well as in patients with myelodysplastic syndrome who present with thrombocytopenia.\u003c\/p\u003e\n\n\u003ch2\u003eComposition\u003c\/h2\u003e\n\u003cp\u003eEach Revolade tablet contains 25 mg of Eltrombopag. It also contains excipients that facilitate its formulation and administration.\u003c\/p\u003e\n\n\u003ch2\u003eContraindications\u003c\/h2\u003e\n\u003cp\u003eRevolade is contraindicated in patients with known hypersensitivity to Eltrombopag or any of the formulation components. It should not be administered to patients with chemotherapy-induced thrombocytopenia and those with a hypercoagulable state.\u003c\/p\u003e\n\n\u003ch2\u003ePrecautions\u003c\/h2\u003e\n\u003cp\u003ePatients are recommended to be monitored regularly to assess platelet count, as well as to detect possible adverse effects. In case of symptoms of hepatotoxicity, such as jaundice or increased transaminases, treatment should be discontinued. Additionally, caution should be exercised in patients with a history of thrombosis or embolism.\u003c\/p\u003e\n\n\u003ch2\u003eStorage\u003c\/h2\u003e\n\u003cp\u003eStore in its original packaging at room temperature, in a dry place and protected from light. Keep out of reach of children.\u003c\/p\u003e\n\n\u003cp\u003ePrescription required.\u003c\/p\u003e\n\u003cp\u003eConsult your doctor.\u003c\/p\u003e","brand":"Glaxo Smith Kline","offers":[{"title":"Default Title","offer_id":45848493129953,"sku":"7501124820602","price":16338.46,"currency_code":"MXN","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0722\/1500\/3361\/files\/7501124820602_db603110-4c68-4d36-af6c-82ea76d46c99.jpg?v=1744688972","url":"https:\/\/wecarepharma.mx\/en\/products\/revolade-25mg-con-28-tabletas-eltrombopag","provider":"WeCare Pharma","version":"1.0","type":"link"}